A Quality Improvement Approach to Rheumatoid Arthritis Management With Biologic Disease-Modifying Antirheumatic Drugs: Assessing Variability in a Treatment Pathway

J Clin Rheumatol. 2017 Jan;23(1):66-69. doi: 10.1097/RHU.0000000000000474.

¹ Division of Rheumatology, Immunology and Allergy, Department of Medicine, Brigham and Women's Hospital, Boston, MA Rheumatology Program, Division of Immunology, Boston Children's Hospital; and Brigham and Women's Hospital, Center for Clinical Excellence, Boston, MA (now with the Division of Rheumatology, Connecticut Children's Medical Center, Hartford, CT) Division of Rheumatology, Immunology and Allergy, Department of Medicine, Brigham and Women's Hospital, Boston, MA Division of Rheumatology, Immunology and Allergy, Department of Medicine, and Division of Pharmacoepidemiology, Brigham and Women's Hospital, Boston, MA Division of Rheumatology, Immunology and Allergy, Department of Medicine, Brigham and Women's Hospital, Boston, MA [email protected].

No abstract available

Publication types